Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA)
CUSIP: 04746L104
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, $0.0001 Par Value
- Shares outstanding
- 9,614,000
- Total 13F shares
- 1,052
- Share change
- -17,546,377
- Total reported value
- $595
- Price per share
- $2.26
- Number of holders
- 2
- Value change
- -$5,301,419
- Number of sells
- 50
Quarterly Holders Quick Answers
What is CUSIP 04746L104?
CUSIP 04746L104 identifies ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 04746L104:
Top shareholders of ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
56%
|
5,402,964
|
$1,631,695 | — | 30 Jun 2025 | |
| BML Capital Management, LLC |
13F
|
Company |
34%
|
3,230,667
|
$975,661 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
16%
|
1,537,914
|
$464,450 | — | 30 Jun 2025 | |
| Propel Bio Management, LLC |
13F
|
Company |
16%
|
1,492,792
|
$450,823 | — | 30 Jun 2025 | |
| Simplify Asset Management Inc. |
13F
|
Company |
16%
|
1,492,792
|
$450,823 | — | 30 Jun 2025 | |
| Hans Moebius |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
91,482
|
$266,213 | — | 04 Jan 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
6.2%
|
600,000
|
$181,200 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
4.3%
|
416,203
|
$125,694 | — | 30 Jun 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
4.2%
|
405,481
|
$120,000 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
3.9%
|
376,454
|
$113,690 | — | 30 Jun 2025 | |
| Pathstone Holdings, LLC |
13F
|
Company |
3.9%
|
372,196
|
$112,403 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
3.2%
|
305,964
|
$92,425 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.5%
|
241,000
|
$72,782 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.2%
|
210,128
|
$63,459 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
2.1%
|
203,475
|
$61,449 | — | 30 Jun 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
2%
|
192,684
|
$58,191 | — | 30 Jun 2025 | |
| Andrew Gengos |
3/4/5
|
CFO and Chief Business Officer |
—
mixed-class rows
|
377,532
mixed-class rows
|
$55,203 | — | 03 Sep 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.6%
|
154,200
|
$46,568 | — | 30 Jun 2025 | |
| Laird Norton Wetherby Trust Company, LLC |
13F
|
Company |
1.3%
|
127,309
|
$38,447 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.1%
|
107,381
|
$32,429 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.84%
|
80,524
|
$24,318 | — | 30 Jun 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.63%
|
60,100
|
$18,030 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.56%
|
53,609
|
$16,190 | — | 30 Jun 2025 | |
| Clarius Group, LLC |
13F
|
Company |
0.56%
|
53,551
|
$16,172 | — | 30 Jun 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.55%
|
52,986
|
$16,002 | — | 30 Jun 2025 | |
| Integrity Financial Corp /WA |
13F
|
Company |
0.55%
|
52,902
|
$15,976 | — | 30 Jun 2025 | |
| Invst, LLC |
13F
|
Company |
0.47%
|
45,000
|
$13,590 | — | 30 Jun 2025 | |
| Rachel Lenington |
3/4/5
|
COO and CDO |
—
mixed-class rows
|
320,870
mixed-class rows
|
$11,812 | — | 03 Sep 2024 | |
| EWA, LLC |
13F
|
Company |
0.37%
|
35,765
|
$10,801 | — | 30 Jun 2025 | |
| BRIGHTON JONES LLC |
13F
|
Company |
0.33%
|
32,200
|
$9,725 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.28%
|
27,156
|
$8,000 | — | 30 Jun 2025 | |
| Virtu Financial LLC |
13F
|
Company |
0.26%
|
24,742
|
$7,000 | — | 30 Jun 2025 | |
| JOURNEY STRATEGIC WEALTH LLC |
13F
|
Company |
0.21%
|
20,538
|
$6,202 | — | 30 Jun 2025 | |
| SIMON QUICK ADVISORS, LLC |
13F
|
Company |
0.21%
|
20,538
|
$6,202 | — | 30 Jun 2025 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.21%
|
20,000
|
$6,040 | — | 30 Jun 2025 | |
| Shay Capital LLC |
13F
|
Company |
0.19%
|
18,586
|
$5,613 | — | 30 Jun 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.17%
|
16,156
|
$4,000 | — | 30 Jun 2025 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.13%
|
12,697
|
$3,835 | — | 30 Jun 2025 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.12%
|
11,680
|
$3,527 | — | 30 Jun 2025 | |
| Engineers Gate Manager LP |
13F
|
Company |
0.11%
|
11,042
|
$3,335 | — | 30 Jun 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.09%
|
9,073
|
$2,740 | — | 30 Jun 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.06%
|
5,500
|
$1,661 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
5,112
|
$1,544 | — | 30 Jun 2025 | |
| American Capital Advisory, LLC |
13F
|
Company |
0.02%
|
2,000
|
$604 | — | 30 Jun 2025 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0.02%
|
2,000
|
$604 | — | 30 Jun 2025 | |
| ROTHSCHILD INVESTMENT LLC |
13F
|
Company |
0.02%
|
1,500
|
$453 | — | 30 Jun 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.01%
|
1,399
|
$422 | — | 30 Jun 2025 | |
| McIlrath & Eck, LLC |
13F
|
Company |
0.01%
|
825
|
$249 | — | 30 Jun 2025 | |
| US BANCORP \DE\ |
13F
|
Company |
0.01%
|
815
|
$246 | — | 30 Jun 2025 | |
| Global Retirement Partners, LLC |
13F
|
Company |
0.01%
|
519
|
$157 | — | 30 Jun 2025 |
Institutional Holders of Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) as of Q3 2025
As of 30 Sep 2025,
Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) was held by
2 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,052 shares.
The largest 2 holders included
OSAIC HOLDINGS, INC. and Global Retirement Partners, LLC.
This page lists
2
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
50
Q3 2025 holders
2
Holder diff
-48
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.